These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36382503)

  • 1. The association between pre-existing asthma and reduced risk of death among children and adolescents hospitalized with COVID-19 in Brazil.
    Oliveira MCL; Colosimo EA; Vasconcelos MA; Martelli-Júnior H; Mak RH; Silva LR; Pinhati CC; Simões E Silva AC; Oliveira EA
    Pediatr Pulmonol; 2023 Mar; 58(3):727-737. PubMed ID: 36382503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database.
    Oliveira EA; Colosimo EA; Simões E Silva AC; Mak RH; Martelli DB; Silva LR; Martelli-Júnior H; Oliveira MCL
    Lancet Child Adolesc Health; 2021 Aug; 5(8):559-568. PubMed ID: 34119027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and risk factors of death among hospitalized children and adolescents with obesity and COVID-19 in Brazil: An analysis of a nationwide database.
    Simões E Silva AC; Vasconcelos MA; Colosimo EA; Mendonça ACQ; Martelli-Júnior H; Silva LR; Oliveira MCL; Pinhati CC; Mak RH; Oliveira EA
    Pediatr Obes; 2022 Sep; 17(9):e12920. PubMed ID: 35481672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for COVID-19-related mortality in hospitalized children and adolescents with diabetes mellitus: An observational retrospective cohort study.
    Oliveira EA; Mak RH; Colosimo EA; Mendonça ACQ; Vasconcelos MA; Martelli-Júnior H; Silva LR; Oliveira MCL; Pinhati CC; Simões E Silva AC
    Pediatr Diabetes; 2022 Sep; 23(6):763-772. PubMed ID: 35307916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and risk factors for death among hospitalized children and adolescents with kidney diseases and COVID-19: an analysis of a nationwide database.
    Vasconcelos MA; Mendonça ACQ; Colosimo EA; Nourbakhsh N; Martelli-Júnior H; Silva LR; Oliveira MCL; Pinhati CC; Mak RH; Simões E Silva AC; Oliveira EA
    Pediatr Nephrol; 2023 Jan; 38(1):181-191. PubMed ID: 35488136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact and Risk Factors of Mortality in Hospitalized Children and Adolescents With Hematologic Diseases and COVID-19: An Observational Retrospective Cohort Study.
    Oliveira MCL; Simões E Silva AC; Colosimo EA; Campos MK; Martelli-Júnior H; Silva LR; Pinhati CC; Mak RH; Oliveira EA
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):e315-e322. PubMed ID: 36044328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries.
    Nachega JB; Sam-Agudu NA; Machekano RN; Rabie H; van der Zalm MM; Redfern A; Dramowski A; O'Connell N; Pipo MT; Tshilanda MB; Byamungu LN; Masekela R; Jeena PM; Pillay A; Gachuno OW; Kinuthia J; Ishoso DK; Amoako E; Agyare E; Agbeno EK; Martyn-Dickens C; Sylverken J; Enimil A; Jibril AM; Abdullahi AM; Amadi O; Umar UM; Sigwadhi LN; Hermans MP; Otokoye JO; Mbala-Kingebeni P; Muyembe-Tamfum JJ; Zumla A; Sewankambo NK; Aanyu HT; Musoke P; Suleman F; Adejumo P; Noormahomed EV; Deckelbaum RJ; Fowler MG; Tshilolo L; Smith G; Mills EJ; Umar LW; Siedner MJ; Kruger M; Rosenthal PJ; Mellors JW; Mofenson LM;
    JAMA Pediatr; 2022 Mar; 176(3):e216436. PubMed ID: 35044430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description and comparison of demographic characteristics and comorbidities in SARI from COVID-19, SARI from influenza, and the Brazilian general population.
    Niquini RP; Lana RM; Pacheco AG; Cruz OG; Coelho FC; Carvalho LM; Villela DAM; Gomes MFDC; Bastos LS
    Cad Saude Publica; 2020; 36(7):e00149420. PubMed ID: 32725087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and risk factors for maternal deaths due to COVID-19 in Brazil: a nationwide population-based cohort study.
    Siqueira TS; de Souza EKG; Martins-Filho PR; Silva JRS; Gurgel RQ; Cuevas LE; Santos VS
    J Travel Med; 2022 May; 29(3):. PubMed ID: 34983057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database.
    de Souza FSH; Hojo-Souza NS; Batista BDO; da Silva CM; Guidoni DL
    PLoS One; 2021; 16(3):e0248580. PubMed ID: 33735272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective cohort of children and adolescents hospitalized by COVID-19 in Brazil from the beginning of the pandemic to August 1st, 2020.
    Gomes NTN; Haslett MIC; Alves AJSE; Percio J; Duarte MMS; Malta JMAS; Carvalho FC; Almeida WAF; Gava C; Souza LRO; Fantinato FFST; Santos EDD
    Rev Bras Epidemiol; 2021; 24():e210026. PubMed ID: 34378752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-communicable diseases, sociodemographic vulnerability and the risk of mortality in hospitalised children and adolescents with COVID-19 in Brazil: a cross-sectional observational study.
    Sousa BLA; Brentani A; Costa Ribeiro CC; Dolhnikoff M; Grisi SJFE; Ferrer APS; Ferraro AA
    BMJ Open; 2021 Sep; 11(9):e050724. PubMed ID: 34489291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma is not a risk factor for severity of SARS-CoV-2 infection in the Mexican population.
    Morales-Romero J; Bedolla-Barajas M
    J Asthma; 2022 Nov; 59(11):2314-2321. PubMed ID: 34818126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
    Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study.
    Shi T; Pan J; Vasileiou E; Robertson C; Sheikh A;
    Lancet Respir Med; 2022 Apr; 10(4):347-354. PubMed ID: 35033224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Coronavirus Disease 2019.
    Campbell JI; Dubois MM; Savage TJ; Hood-Pishchany MI; Sharma TS; Petty CR; Lamb GS; Nakamura MM;
    J Pediatr; 2022 Jun; 245():102-110.e2. PubMed ID: 35240138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalizations and deaths of children and adolescents with Severe Acute Respiratory Infection due to COVID-19 during the epidemiological year of 2020.
    Soares MCB; Freitas BAC; Toledo LV; Mendes IR; Quintão APC; Souza SM
    Rev Inst Med Trop Sao Paulo; 2023; 65():e11. PubMed ID: 36722673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
    Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J
    Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.